United States C1 Esterase Inhibitor Market Report 2018

March 2018 | 104 pages | ID: UAA33F1829DEN
QYResearch

Abstracts

In this report, the United States C1 Esterase Inhibitor market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of C1 Esterase Inhibitor in these regions, from 2013 to 2025 (forecast).

United States C1 Esterase Inhibitor market competition by top manufacturers/players, with C1 Esterase Inhibitor sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• CSL Behring
• Lev Pharmaceuticals
• Salix Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Human
• Recombinant

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Pharmacy

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States C1 Esterase Inhibitor Market Report 2018

1 C1 ESTERASE INHIBITOR OVERVIEW

1.1 Product Overview and Scope of C1 Esterase Inhibitor
1.2 Classification of C1 Esterase Inhibitor by Product Category
  1.2.1 United States C1 Esterase Inhibitor Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States C1 Esterase Inhibitor Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Human
  1.2.4 Recombinant
1.3 United States C1 Esterase Inhibitor Market by Application/End Users
  1.3.1 United States C1 Esterase Inhibitor Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospital
  1.3.3 Pharmacy
1.4 United States C1 Esterase Inhibitor Market by Region
  1.4.1 United States C1 Esterase Inhibitor Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West C1 Esterase Inhibitor Status and Prospect (2013-2025)
  1.4.3 Southwest C1 Esterase Inhibitor Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic C1 Esterase Inhibitor Status and Prospect (2013-2025)
  1.4.5 New England C1 Esterase Inhibitor Status and Prospect (2013-2025)
  1.4.6 The South C1 Esterase Inhibitor Status and Prospect (2013-2025)
  1.4.7 The Midwest C1 Esterase Inhibitor Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of C1 Esterase Inhibitor (2013-2025)
  1.5.1 United States C1 Esterase Inhibitor Sales and Growth Rate (2013-2025)
  1.5.2 United States C1 Esterase Inhibitor Revenue and Growth Rate (2013-2025)

2 UNITED STATES C1 ESTERASE INHIBITOR MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States C1 Esterase Inhibitor Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States C1 Esterase Inhibitor Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States C1 Esterase Inhibitor Average Price by Players/Suppliers (2013-2018)
2.4 United States C1 Esterase Inhibitor Market Competitive Situation and Trends
  2.4.1 United States C1 Esterase Inhibitor Market Concentration Rate
  2.4.2 United States C1 Esterase Inhibitor Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers C1 Esterase Inhibitor Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES C1 ESTERASE INHIBITOR SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States C1 Esterase Inhibitor Sales and Market Share by Region (2013-2018)
3.2 United States C1 Esterase Inhibitor Revenue and Market Share by Region (2013-2018)
3.3 United States C1 Esterase Inhibitor Price by Region (2013-2018)

4 UNITED STATES C1 ESTERASE INHIBITOR SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States C1 Esterase Inhibitor Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States C1 Esterase Inhibitor Revenue and Market Share by Type (2013-2018)
4.3 United States C1 Esterase Inhibitor Price by Type (2013-2018)
4.4 United States C1 Esterase Inhibitor Sales Growth Rate by Type (2013-2018)

5 UNITED STATES C1 ESTERASE INHIBITOR SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States C1 Esterase Inhibitor Sales and Market Share by Application (2013-2018)
5.2 United States C1 Esterase Inhibitor Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES C1 ESTERASE INHIBITOR PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 CSL Behring
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 C1 Esterase Inhibitor Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 CSL Behring C1 Esterase Inhibitor Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Lev Pharmaceuticals
  6.2.2 C1 Esterase Inhibitor Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Lev Pharmaceuticals C1 Esterase Inhibitor Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Salix Pharmaceuticals
  6.3.2 C1 Esterase Inhibitor Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Salix Pharmaceuticals C1 Esterase Inhibitor Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview

7 C1 ESTERASE INHIBITOR MANUFACTURING COST ANALYSIS

7.1 C1 Esterase Inhibitor Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of C1 Esterase Inhibitor

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 C1 Esterase Inhibitor Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of C1 Esterase Inhibitor Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES C1 ESTERASE INHIBITOR MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States C1 Esterase Inhibitor Sales Volume, Revenue Forecast (2018-2025)
11.2 United States C1 Esterase Inhibitor Sales Volume Forecast by Type (2018-2025)
11.3 United States C1 Esterase Inhibitor Sales Volume Forecast by Application (2018-2025)
11.4 United States C1 Esterase Inhibitor Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of C1 Esterase Inhibitor
Figure United States C1 Esterase Inhibitor Market Size (K Units) by Type (2013-2025)
Figure United States C1 Esterase Inhibitor Sales Volume Market Share by Type (Product Category) in 2017
Figure Human Product Picture
Figure Recombinant Product Picture
Figure United States C1 Esterase Inhibitor Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of C1 Esterase Inhibitor by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Pharmacy Examples
Table Key Downstream Customer in Pharmacy
Figure United States C1 Esterase Inhibitor Market Size (Million USD) by Region (2013-2025)
Figure The West C1 Esterase Inhibitor Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest C1 Esterase Inhibitor Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic C1 Esterase Inhibitor Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England C1 Esterase Inhibitor Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US C1 Esterase Inhibitor Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest C1 Esterase Inhibitor Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States C1 Esterase Inhibitor Sales (K Units) and Growth Rate (2013-2025)
Figure United States C1 Esterase Inhibitor Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States C1 Esterase Inhibitor Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States C1 Esterase Inhibitor Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States C1 Esterase Inhibitor Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States C1 Esterase Inhibitor Sales Share by Players/Suppliers
Figure 2017 United States C1 Esterase Inhibitor Sales Share by Players/Suppliers
Figure United States C1 Esterase Inhibitor Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States C1 Esterase Inhibitor Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States C1 Esterase Inhibitor Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States C1 Esterase Inhibitor Revenue Share by Players/Suppliers
Figure 2017 United States C1 Esterase Inhibitor Revenue Share by Players/Suppliers
Table United States Market C1 Esterase Inhibitor Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market C1 Esterase Inhibitor Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States C1 Esterase Inhibitor Market Share of Top 3 Players/Suppliers
Figure United States C1 Esterase Inhibitor Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers C1 Esterase Inhibitor Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers C1 Esterase Inhibitor Product Category
Table United States C1 Esterase Inhibitor Sales (K Units) by Region (2013-2018)
Table United States C1 Esterase Inhibitor Sales Share by Region (2013-2018)
Figure United States C1 Esterase Inhibitor Sales Share by Region (2013-2018)
Figure United States C1 Esterase Inhibitor Sales Market Share by Region in 2017
Table United States C1 Esterase Inhibitor Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States C1 Esterase Inhibitor Revenue Share by Region (2013-2018)
Figure United States C1 Esterase Inhibitor Revenue Market Share by Region (2013-2018)
Figure United States C1 Esterase Inhibitor Revenue Market Share by Region in 2017
Table United States C1 Esterase Inhibitor Price (USD/Unit) by Region (2013-2018)
Table United States C1 Esterase Inhibitor Sales (K Units) by Type (2013-2018)
Table United States C1 Esterase Inhibitor Sales Share by Type (2013-2018)
Figure United States C1 Esterase Inhibitor Sales Share by Type (2013-2018)
Figure United States C1 Esterase Inhibitor Sales Market Share by Type in 2017
Table United States C1 Esterase Inhibitor Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States C1 Esterase Inhibitor Revenue Share by Type (2013-2018)
Figure Revenue Market Share of C1 Esterase Inhibitor by Type (2013-2018)
Figure Revenue Market Share of C1 Esterase Inhibitor by Type in 2017
Table United States C1 Esterase Inhibitor Price (USD/Unit) by Types (2013-2018)
Figure United States C1 Esterase Inhibitor Sales Growth Rate by Type (2013-2018)
Table United States C1 Esterase Inhibitor Sales (K Units) by Application (2013-2018)
Table United States C1 Esterase Inhibitor Sales Market Share by Application (2013-2018)
Figure United States C1 Esterase Inhibitor Sales Market Share by Application (2013-2018)
Figure United States C1 Esterase Inhibitor Sales Market Share by Application in 2017
Table United States C1 Esterase Inhibitor Sales Growth Rate by Application (2013-2018)
Figure United States C1 Esterase Inhibitor Sales Growth Rate by Application (2013-2018)
Table CSL Behring Basic Information List
Table CSL Behring C1 Esterase Inhibitor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure CSL Behring C1 Esterase Inhibitor Sales Growth Rate (2013-2018)
Figure CSL Behring C1 Esterase Inhibitor Sales Market Share in United States (2013-2018)
Figure CSL Behring C1 Esterase Inhibitor Revenue Market Share in United States (2013-2018)
Table Lev Pharmaceuticals Basic Information List
Table Lev Pharmaceuticals C1 Esterase Inhibitor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Lev Pharmaceuticals C1 Esterase Inhibitor Sales Growth Rate (2013-2018)
Figure Lev Pharmaceuticals C1 Esterase Inhibitor Sales Market Share in United States (2013-2018)
Figure Lev Pharmaceuticals C1 Esterase Inhibitor Revenue Market Share in United States (2013-2018)
Table Salix Pharmaceuticals Basic Information List
Table Salix Pharmaceuticals C1 Esterase Inhibitor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Salix Pharmaceuticals C1 Esterase Inhibitor Sales Growth Rate (2013-2018)
Figure Salix Pharmaceuticals C1 Esterase Inhibitor Sales Market Share in United States (2013-2018)
Figure Salix Pharmaceuticals C1 Esterase Inhibitor Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of C1 Esterase Inhibitor
Figure Manufacturing Process Analysis of C1 Esterase Inhibitor
Figure C1 Esterase Inhibitor Industrial Chain Analysis
Table Raw Materials Sources of C1 Esterase Inhibitor Major Players/Suppliers in 2017
Table Major Buyers of C1 Esterase Inhibitor
Table Distributors/Traders List
Figure United States C1 Esterase Inhibitor Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States C1 Esterase Inhibitor Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States C1 Esterase Inhibitor Price (USD/Unit) Trend Forecast (2018-2025)
Table United States C1 Esterase Inhibitor Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States C1 Esterase Inhibitor Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States C1 Esterase Inhibitor Sales Volume (K Units) Forecast by Type in 2025
Table United States C1 Esterase Inhibitor Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States C1 Esterase Inhibitor Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States C1 Esterase Inhibitor Sales Volume (K Units) Forecast by Application in 2025
Table United States C1 Esterase Inhibitor Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States C1 Esterase Inhibitor Sales Volume Share Forecast by Region (2018-2025)
Figure United States C1 Esterase Inhibitor Sales Volume Share Forecast by Region (2018-2025)
Figure United States C1 Esterase Inhibitor Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources